| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 51 | 2022 | 181 | 12.010 |
Why?
|
| Blood Vessel Prosthesis | 48 | 2022 | 228 | 10.410 |
Why?
|
| Tissue Scaffolds | 30 | 2022 | 106 | 6.770 |
Why?
|
| Printing, Three-Dimensional | 15 | 2021 | 37 | 6.550 |
Why?
|
| Blood Vessel Prosthesis Implantation | 23 | 2019 | 208 | 4.900 |
Why?
|
| Cardiac Surgical Procedures | 26 | 2022 | 462 | 4.720 |
Why?
|
| Heart Defects, Congenital | 24 | 2023 | 351 | 4.400 |
Why?
|
| Bioprinting | 7 | 2020 | 13 | 4.030 |
Why?
|
| Biocompatible Materials | 14 | 2022 | 193 | 3.270 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2021 | 104 | 3.140 |
Why?
|
| Myocytes, Cardiac | 7 | 2024 | 275 | 2.920 |
Why?
|
| Loeys-Dietz Syndrome | 7 | 2021 | 21 | 2.640 |
Why?
|
| Aortic Valve | 13 | 2023 | 222 | 2.510 |
Why?
|
| Spheroids, Cellular | 7 | 2020 | 31 | 2.490 |
Why?
|
| Extracellular Matrix | 10 | 2022 | 232 | 2.470 |
Why?
|
| Nanofibers | 5 | 2022 | 31 | 2.320 |
Why?
|
| Aortic Valve Stenosis | 6 | 2023 | 131 | 2.150 |
Why?
|
| Pulmonary Artery | 13 | 2022 | 306 | 2.080 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2021 | 130 | 1.970 |
Why?
|
| Polyesters | 10 | 2020 | 41 | 1.870 |
Why?
|
| Computer-Aided Design | 6 | 2020 | 18 | 1.800 |
Why?
|
| Absorbable Implants | 7 | 2018 | 34 | 1.760 |
Why?
|
| Fontan Procedure | 12 | 2022 | 53 | 1.760 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2023 | 72 | 1.710 |
Why?
|
| Bone Marrow Cells | 11 | 2017 | 253 | 1.600 |
Why?
|
| Heart Valve Prosthesis | 4 | 2023 | 93 | 1.560 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2022 | 38 | 1.530 |
Why?
|
| Heart Transplantation | 6 | 2021 | 705 | 1.520 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2022 | 41 | 1.500 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 139 | 1.480 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2023 | 166 | 1.460 |
Why?
|
| Myocardium | 6 | 2021 | 529 | 1.450 |
Why?
|
| Vena Cava, Inferior | 10 | 2016 | 143 | 1.440 |
Why?
|
| Heart Ventricles | 10 | 2017 | 760 | 1.440 |
Why?
|
| Prosthesis Design | 11 | 2023 | 278 | 1.410 |
Why?
|
| Coronary Vessels | 3 | 2022 | 177 | 1.390 |
Why?
|
| Vascular Grafting | 6 | 2020 | 15 | 1.380 |
Why?
|
| Models, Anatomic | 4 | 2018 | 91 | 1.380 |
Why?
|
| Vascular Surgical Procedures | 8 | 2021 | 148 | 1.340 |
Why?
|
| Bioprosthesis | 7 | 2020 | 36 | 1.340 |
Why?
|
| Infant | 24 | 2022 | 3046 | 1.300 |
Why?
|
| Aneurysm, False | 3 | 2018 | 54 | 1.280 |
Why?
|
| Animals | 59 | 2024 | 26582 | 1.280 |
Why?
|
| Humans | 130 | 2023 | 86643 | 1.280 |
Why?
|
| Pulmonary Valve | 4 | 2022 | 32 | 1.250 |
Why?
|
| Nanotechnology | 2 | 2020 | 68 | 1.250 |
Why?
|
| Regenerative Medicine | 2 | 2018 | 23 | 1.240 |
Why?
|
| Polyglycolic Acid | 8 | 2022 | 9 | 1.230 |
Why?
|
| Chitosan | 2 | 2018 | 18 | 1.220 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2016 | 231 | 1.140 |
Why?
|
| Aorta | 10 | 2022 | 280 | 1.140 |
Why?
|
| Double Outlet Right Ventricle | 3 | 2022 | 6 | 1.130 |
Why?
|
| Models, Cardiovascular | 6 | 2022 | 98 | 1.120 |
Why?
|
| Blood Vessels | 7 | 2017 | 94 | 1.080 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 346 | 1.050 |
Why?
|
| Fibroblasts | 4 | 2021 | 729 | 1.010 |
Why?
|
| Aorta, Thoracic | 7 | 2022 | 165 | 1.000 |
Why?
|
| Postoperative Complications | 11 | 2020 | 2207 | 0.990 |
Why?
|
| Mitral Valve | 6 | 2020 | 248 | 0.970 |
Why?
|
| Pericardium | 5 | 2020 | 65 | 0.950 |
Why?
|
| Regeneration | 3 | 2019 | 143 | 0.950 |
Why?
|
| Aortic Coarctation | 5 | 2021 | 35 | 0.940 |
Why?
|
| Neovascularization, Physiologic | 3 | 2020 | 133 | 0.940 |
Why?
|
| Tetralogy of Fallot | 2 | 2022 | 44 | 0.940 |
Why?
|
| Hydrogels | 3 | 2022 | 82 | 0.940 |
Why?
|
| Rats | 11 | 2024 | 3990 | 0.930 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2022 | 18 | 0.890 |
Why?
|
| Myocardial Contraction | 2 | 2021 | 244 | 0.850 |
Why?
|
| Stress, Mechanical | 4 | 2021 | 248 | 0.840 |
Why?
|
| Female | 62 | 2022 | 44532 | 0.840 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2020 | 187 | 0.840 |
Why?
|
| Glycerol | 1 | 2022 | 32 | 0.830 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2021 | 87 | 0.820 |
Why?
|
| Heart | 4 | 2024 | 539 | 0.800 |
Why?
|
| Tacrolimus | 1 | 2022 | 373 | 0.790 |
Why?
|
| Models, Animal | 10 | 2024 | 263 | 0.780 |
Why?
|
| Coronary Occlusion | 1 | 2020 | 7 | 0.770 |
Why?
|
| Respiratory Paralysis | 1 | 2020 | 8 | 0.760 |
Why?
|
| Child | 30 | 2022 | 6927 | 0.760 |
Why?
|
| Phrenic Nerve | 1 | 2020 | 42 | 0.760 |
Why?
|
| Diaphragm | 1 | 2020 | 50 | 0.750 |
Why?
|
| Reoperation | 12 | 2021 | 597 | 0.740 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 579 | 0.740 |
Why?
|
| Mice | 29 | 2024 | 11352 | 0.730 |
Why?
|
| Heart Failure | 6 | 2019 | 1204 | 0.730 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2015 | 99 | 0.730 |
Why?
|
| Infant, Newborn | 14 | 2023 | 2379 | 0.720 |
Why?
|
| Cells, Immobilized | 1 | 2019 | 2 | 0.720 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2019 | 148 | 0.700 |
Why?
|
| Constriction, Pathologic | 6 | 2020 | 213 | 0.700 |
Why?
|
| Ultrasonic Therapy | 1 | 2019 | 32 | 0.700 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2016 | 132 | 0.700 |
Why?
|
| Aortic Aneurysm | 2 | 2018 | 80 | 0.700 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2016 | 196 | 0.680 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2017 | 21 | 0.670 |
Why?
|
| Treatment Outcome | 21 | 2023 | 7993 | 0.650 |
Why?
|
| Coronary Aneurysm | 1 | 2018 | 16 | 0.640 |
Why?
|
| Tunica Intima | 1 | 2018 | 59 | 0.640 |
Why?
|
| Time Factors | 16 | 2021 | 5210 | 0.630 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 49 | 0.630 |
Why?
|
| Macrophages | 4 | 2016 | 554 | 0.620 |
Why?
|
| Cells, Cultured | 12 | 2021 | 2818 | 0.610 |
Why?
|
| Retrospective Studies | 22 | 2022 | 8489 | 0.610 |
Why?
|
| Heart Arrest | 1 | 2020 | 265 | 0.600 |
Why?
|
| Sheep | 7 | 2020 | 239 | 0.590 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 99 | 0.590 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 6 | 2021 | 63 | 0.580 |
Why?
|
| Child, Preschool | 21 | 2021 | 3612 | 0.580 |
Why?
|
| Transplants | 2 | 2015 | 40 | 0.580 |
Why?
|
| Simulation Training | 1 | 2018 | 88 | 0.580 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2017 | 71 | 0.570 |
Why?
|
| Polymers | 7 | 2019 | 202 | 0.570 |
Why?
|
| Hemodynamics | 11 | 2022 | 710 | 0.560 |
Why?
|
| Nanostructures | 1 | 2016 | 77 | 0.550 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2020 | 111 | 0.540 |
Why?
|
| Cesarean Section | 1 | 2016 | 137 | 0.540 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2020 | 67 | 0.530 |
Why?
|
| Rats, Inbred Lew | 3 | 2019 | 186 | 0.510 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 121 | 0.510 |
Why?
|
| Male | 48 | 2021 | 40965 | 0.510 |
Why?
|
| Bone Marrow Transplantation | 5 | 2011 | 286 | 0.470 |
Why?
|
| Endothelial Cells | 5 | 2022 | 428 | 0.470 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 164 | 0.470 |
Why?
|
| Adolescent | 16 | 2021 | 8981 | 0.460 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 18 | 0.450 |
Why?
|
| Mice, SCID | 8 | 2015 | 252 | 0.440 |
Why?
|
| Stents | 1 | 2015 | 377 | 0.440 |
Why?
|
| Computed Tomography Angiography | 3 | 2019 | 131 | 0.430 |
Why?
|
| Guided Tissue Regeneration | 2 | 2011 | 7 | 0.430 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2011 | 112 | 0.410 |
Why?
|
| Vascular Fistula | 2 | 2003 | 12 | 0.410 |
Why?
|
| Filtration | 1 | 2011 | 25 | 0.410 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1920 | 0.400 |
Why?
|
| Immunity, Innate | 1 | 2015 | 409 | 0.400 |
Why?
|
| Cell Differentiation | 7 | 2021 | 1458 | 0.400 |
Why?
|
| Transplantation, Autologous | 7 | 2017 | 331 | 0.390 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2012 | 64 | 0.390 |
Why?
|
| Rats, Nude | 3 | 2019 | 22 | 0.390 |
Why?
|
| Cell Separation | 1 | 2011 | 196 | 0.390 |
Why?
|
| Pulmonary Veins | 4 | 2012 | 72 | 0.390 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 1753 | 0.390 |
Why?
|
| Patient-Specific Modeling | 3 | 2020 | 19 | 0.390 |
Why?
|
| MicroRNAs | 1 | 2015 | 534 | 0.380 |
Why?
|
| Endothelium, Vascular | 4 | 2019 | 435 | 0.380 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 2232 | 0.380 |
Why?
|
| Neointima | 2 | 2022 | 13 | 0.370 |
Why?
|
| Databases, Factual | 4 | 2021 | 814 | 0.370 |
Why?
|
| Aneurysm | 2 | 2018 | 58 | 0.370 |
Why?
|
| Intraoperative Care | 2 | 2020 | 82 | 0.360 |
Why?
|
| Aortic Diseases | 2 | 2016 | 100 | 0.350 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 797 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 9 | 2017 | 3092 | 0.340 |
Why?
|
| Forecasting | 3 | 2023 | 304 | 0.320 |
Why?
|
| Dogs | 6 | 2020 | 685 | 0.320 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2008 | 16 | 0.320 |
Why?
|
| Phlebotomy | 1 | 2008 | 21 | 0.320 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 2022 | 6 | 0.320 |
Why?
|
| Blood Donors | 1 | 2008 | 26 | 0.310 |
Why?
|
| Abnormalities, Multiple | 3 | 2008 | 232 | 0.310 |
Why?
|
| Electrocardiography | 2 | 2020 | 478 | 0.310 |
Why?
|
| Coronary Angiography | 2 | 2019 | 232 | 0.300 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 112 | 0.300 |
Why?
|
| Tricuspid Valve | 3 | 2020 | 96 | 0.300 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 3640 | 0.280 |
Why?
|
| Monocytes | 3 | 2015 | 214 | 0.280 |
Why?
|
| Lactic Acid | 4 | 2012 | 90 | 0.280 |
Why?
|
| Vascular Remodeling | 2 | 2016 | 21 | 0.280 |
Why?
|
| Robotic Surgical Procedures | 3 | 2020 | 267 | 0.280 |
Why?
|
| Echocardiography | 5 | 2020 | 911 | 0.280 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1578 | 0.280 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2016 | 40 | 0.270 |
Why?
|
| Cell Survival | 4 | 2019 | 969 | 0.270 |
Why?
|
| Preoperative Care | 1 | 2008 | 397 | 0.260 |
Why?
|
| Swine | 3 | 2024 | 555 | 0.260 |
Why?
|
| Cytokines | 3 | 2020 | 776 | 0.260 |
Why?
|
| Equipment Design | 2 | 2024 | 406 | 0.260 |
Why?
|
| Vascular Patency | 3 | 2016 | 126 | 0.260 |
Why?
|
| Cardiac Catheterization | 3 | 2020 | 291 | 0.250 |
Why?
|
| Adult | 19 | 2022 | 25648 | 0.250 |
Why?
|
| Silicon | 1 | 2024 | 18 | 0.240 |
Why?
|
| Tensile Strength | 3 | 2020 | 79 | 0.240 |
Why?
|
| Ligation | 3 | 2019 | 51 | 0.240 |
Why?
|
| Heart Injuries | 1 | 2003 | 16 | 0.230 |
Why?
|
| Pacemaker, Artificial | 1 | 2024 | 87 | 0.230 |
Why?
|
| Tricuspid Atresia | 1 | 2022 | 4 | 0.230 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2024 | 68 | 0.230 |
Why?
|
| Aortic Stenosis, Supravalvular | 2 | 2017 | 4 | 0.220 |
Why?
|
| Sutures | 1 | 2022 | 52 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2022 | 148 | 0.220 |
Why?
|
| Cell Line | 3 | 2019 | 2468 | 0.220 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 1540 | 0.210 |
Why?
|
| Biomarkers | 3 | 2021 | 1718 | 0.210 |
Why?
|
| Tissue Transplantation | 2 | 2017 | 12 | 0.210 |
Why?
|
| Suture Techniques | 1 | 2023 | 135 | 0.210 |
Why?
|
| Autografts | 2 | 2021 | 28 | 0.210 |
Why?
|
| Polydioxanone | 1 | 2021 | 4 | 0.210 |
Why?
|
| Colforsin | 1 | 2001 | 74 | 0.210 |
Why?
|
| Biomedical Engineering | 1 | 2001 | 20 | 0.200 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2001 | 36 | 0.200 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2003 | 134 | 0.200 |
Why?
|
| Arteries | 2 | 2019 | 176 | 0.200 |
Why?
|
| ABO Blood-Group System | 1 | 2021 | 62 | 0.200 |
Why?
|
| Recovery of Function | 2 | 2020 | 272 | 0.200 |
Why?
|
| Balloon Valvuloplasty | 1 | 2021 | 8 | 0.200 |
Why?
|
| Sarcomeres | 1 | 2021 | 23 | 0.200 |
Why?
|
| Heart Atria | 3 | 2020 | 250 | 0.200 |
Why?
|
| Feasibility Studies | 3 | 2019 | 751 | 0.200 |
Why?
|
| Graft Survival | 3 | 2021 | 884 | 0.200 |
Why?
|
| Milrinone | 1 | 2000 | 5 | 0.200 |
Why?
|
| Cryopreservation | 1 | 2001 | 69 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2019 | 152 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 123 | 0.190 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 152 | 0.190 |
Why?
|
| Receptors, Notch | 1 | 2021 | 120 | 0.190 |
Why?
|
| Endoscopy | 2 | 2024 | 332 | 0.190 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 30 | 0.190 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2000 | 39 | 0.190 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 48 | 0.190 |
Why?
|
| Cardiac Electrophysiology | 1 | 2020 | 4 | 0.190 |
Why?
|
| Ultrasonography | 3 | 2012 | 695 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2021 | 344 | 0.190 |
Why?
|
| Vena Cava, Superior | 3 | 2012 | 59 | 0.190 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 202 | 0.190 |
Why?
|
| Burns, Inhalation | 1 | 2020 | 4 | 0.180 |
Why?
|
| Primary Graft Dysfunction | 1 | 2020 | 27 | 0.180 |
Why?
|
| Risk Assessment | 4 | 2019 | 2261 | 0.180 |
Why?
|
| Angioplasty, Laser | 1 | 1999 | 1 | 0.180 |
Why?
|
| Coculture Techniques | 1 | 2020 | 164 | 0.180 |
Why?
|
| Collagen | 2 | 2019 | 269 | 0.180 |
Why?
|
| Angiography | 2 | 2015 | 208 | 0.180 |
Why?
|
| Heart Aneurysm | 1 | 2019 | 22 | 0.180 |
Why?
|
| Polypropylenes | 2 | 2020 | 23 | 0.180 |
Why?
|
| Myocardial Revascularization | 1 | 1999 | 31 | 0.170 |
Why?
|
| Fumarates | 2 | 2020 | 26 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2020 | 98 | 0.170 |
Why?
|
| Cell Size | 1 | 2019 | 65 | 0.170 |
Why?
|
| Membranes, Artificial | 2 | 2010 | 40 | 0.170 |
Why?
|
| Fetal Heart | 1 | 2018 | 13 | 0.170 |
Why?
|
| Fistula | 1 | 1999 | 42 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 185 | 0.170 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 14 | 0.170 |
Why?
|
| Rabbits | 1 | 2020 | 636 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 135 | 0.170 |
Why?
|
| Replantation | 1 | 2018 | 36 | 0.170 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 363 | 0.160 |
Why?
|
| Exosomes | 1 | 2019 | 50 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 38 | 0.160 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 26 | 0.160 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 989 | 0.160 |
Why?
|
| Cell Culture Techniques | 5 | 2016 | 188 | 0.160 |
Why?
|
| Risk Factors | 5 | 2020 | 5417 | 0.160 |
Why?
|
| Artificial Organs | 1 | 2017 | 3 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 150 | 0.160 |
Why?
|
| Goals | 1 | 2018 | 67 | 0.160 |
Why?
|
| Hemorheology | 1 | 2017 | 7 | 0.160 |
Why?
|
| Coronary Disease | 1 | 1999 | 261 | 0.160 |
Why?
|
| Virtual Reality | 1 | 2018 | 21 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 78 | 0.160 |
Why?
|
| Registries | 1 | 2021 | 702 | 0.150 |
Why?
|
| Ultrasonics | 1 | 2017 | 38 | 0.150 |
Why?
|
| Lasers | 1 | 2017 | 106 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 125 | 0.150 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 996 | 0.150 |
Why?
|
| Biomimetic Materials | 1 | 2017 | 22 | 0.150 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 49 | 0.150 |
Why?
|
| Nervous System | 1 | 2017 | 86 | 0.150 |
Why?
|
| Cardiovascular System | 1 | 2017 | 71 | 0.150 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 6 | 0.150 |
Why?
|
| Venous Pressure | 1 | 2016 | 11 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2019 | 175 | 0.150 |
Why?
|
| Phlebography | 1 | 2016 | 66 | 0.150 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 53 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 2601 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2016 | 16 | 0.140 |
Why?
|
| Cell-Free System | 1 | 2016 | 51 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2019 | 263 | 0.140 |
Why?
|
| Bioreactors | 1 | 2016 | 10 | 0.140 |
Why?
|
| Heart Diseases | 1 | 1999 | 290 | 0.140 |
Why?
|
| Liver | 2 | 2021 | 1230 | 0.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 58 | 0.140 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2016 | 13 | 0.140 |
Why?
|
| Dyspnea | 1 | 2016 | 73 | 0.140 |
Why?
|
| Cardiology | 1 | 2017 | 123 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2017 | 265 | 0.140 |
Why?
|
| Pregnancy | 3 | 2019 | 2894 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 318 | 0.140 |
Why?
|
| Diverticulum | 1 | 2016 | 44 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2016 | 60 | 0.140 |
Why?
|
| Incidence | 1 | 2020 | 1577 | 0.140 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 67 | 0.140 |
Why?
|
| Shock, Cardiogenic | 1 | 2016 | 95 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 109 | 0.140 |
Why?
|
| Gestational Age | 1 | 2016 | 311 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1801 | 0.130 |
Why?
|
| Surgeons | 1 | 2020 | 238 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2021 | 1065 | 0.130 |
Why?
|
| Wound Healing | 1 | 2017 | 344 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 240 | 0.130 |
Why?
|
| Dioxoles | 1 | 2015 | 5 | 0.130 |
Why?
|
| Tetrazoles | 1 | 2015 | 50 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2015 | 30 | 0.130 |
Why?
|
| Patient Selection | 1 | 2018 | 685 | 0.130 |
Why?
|
| Thrombosis | 1 | 2017 | 296 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 141 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2015 | 149 | 0.120 |
Why?
|
| Trachea | 1 | 2015 | 293 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 449 | 0.120 |
Why?
|
| Ilizarov Technique | 1 | 2013 | 1 | 0.120 |
Why?
|
| Skin | 1 | 2017 | 554 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 154 | 0.120 |
Why?
|
| Heparin | 1 | 2015 | 175 | 0.120 |
Why?
|
| Finger Joint | 1 | 2013 | 14 | 0.120 |
Why?
|
| Immune System | 1 | 2015 | 93 | 0.120 |
Why?
|
| Inflammation | 2 | 2017 | 920 | 0.120 |
Why?
|
| Software | 1 | 2018 | 654 | 0.120 |
Why?
|
| Benzamides | 1 | 2015 | 229 | 0.120 |
Why?
|
| Pulmonary Circulation | 2 | 2017 | 86 | 0.120 |
Why?
|
| Contracture | 1 | 2013 | 18 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2017 | 572 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 13 | 0.120 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 267 | 0.110 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2003 | 9 | 0.110 |
Why?
|
| Coronary Artery Bypass | 2 | 2006 | 228 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 879 | 0.110 |
Why?
|
| Metacarpal Bones | 1 | 2012 | 10 | 0.110 |
Why?
|
| Lung | 1 | 2019 | 1170 | 0.110 |
Why?
|
| Catheterization | 1 | 2014 | 232 | 0.110 |
Why?
|
| Body Weight | 1 | 2014 | 459 | 0.110 |
Why?
|
| Young Adult | 3 | 2020 | 5976 | 0.110 |
Why?
|
| Y Chromosome | 1 | 2012 | 28 | 0.110 |
Why?
|
| United States | 3 | 2020 | 6672 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 3362 | 0.100 |
Why?
|
| Caproates | 2 | 2016 | 7 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1268 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2012 | 31 | 0.100 |
Why?
|
| Lactones | 2 | 2016 | 28 | 0.100 |
Why?
|
| Transplantation, Isogeneic | 1 | 2011 | 39 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 731 | 0.100 |
Why?
|
| Random Allocation | 2 | 2016 | 332 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 348 | 0.100 |
Why?
|
| Survival Rate | 3 | 2021 | 1863 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 273 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2021 | 3241 | 0.100 |
Why?
|
| Fibrin | 2 | 2022 | 84 | 0.100 |
Why?
|
| Gene Expression | 1 | 2015 | 1284 | 0.090 |
Why?
|
| Cell Transplantation | 1 | 2010 | 47 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 2021 | 197 | 0.090 |
Why?
|
| Venae Cavae | 1 | 2010 | 14 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 724 | 0.090 |
Why?
|
| Workflow | 2 | 2022 | 77 | 0.090 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2010 | 44 | 0.090 |
Why?
|
| Ductus Arteriosus | 1 | 2009 | 26 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2011 | 679 | 0.090 |
Why?
|
| Hydrodynamics | 2 | 2020 | 18 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2011 | 444 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 301 | 0.090 |
Why?
|
| Stem Cells | 2 | 2023 | 351 | 0.090 |
Why?
|
| Pulmonary Atresia | 1 | 2008 | 12 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 2008 | 35 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 425 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1195 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 74 | 0.080 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 50 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2008 | 130 | 0.080 |
Why?
|
| Hyaluronic Acid | 1 | 2008 | 49 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2019 | 4213 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2008 | 179 | 0.080 |
Why?
|
| Heart Valves | 1 | 2006 | 13 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 859 | 0.070 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2005 | 15 | 0.070 |
Why?
|
| Magnesium | 1 | 2006 | 177 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 860 | 0.070 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.070 |
Why?
|
| Collagen Type IV | 1 | 2005 | 24 | 0.070 |
Why?
|
| Femoral Vein | 1 | 2005 | 35 | 0.070 |
Why?
|
| Apoptosis | 1 | 2012 | 1683 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1673 | 0.060 |
Why?
|
| Cardiac Volume | 1 | 2005 | 53 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2020 | 1143 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2018 | 1538 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 503 | 0.060 |
Why?
|
| Ventricular Function, Right | 1 | 2005 | 142 | 0.060 |
Why?
|
| Semiconductors | 1 | 2024 | 11 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2005 | 121 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 2006 | 241 | 0.060 |
Why?
|
| Heart Bypass, Right | 1 | 2003 | 12 | 0.060 |
Why?
|
| Vacuum | 2 | 2015 | 10 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1239 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 827 | 0.060 |
Why?
|
| Middle Aged | 9 | 2013 | 25028 | 0.060 |
Why?
|
| Perfusion | 2 | 2016 | 203 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2003 | 61 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1805 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2003 | 27 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2003 | 46 | 0.060 |
Why?
|
| Heart Arrest, Induced | 1 | 2002 | 31 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2003 | 111 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2019 | 303 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2024 | 162 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2022 | 29 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 288 | 0.050 |
Why?
|
| Uncertainty | 1 | 2022 | 71 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2003 | 129 | 0.050 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 237 | 0.050 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2021 | 7 | 0.050 |
Why?
|
| GATA4 Transcription Factor | 1 | 2021 | 17 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 11 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 267 | 0.050 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2001 | 6 | 0.050 |
Why?
|
| Organ Preservation Solutions | 1 | 2001 | 28 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2001 | 100 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2022 | 127 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2001 | 38 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 839 | 0.050 |
Why?
|
| Mesoderm | 1 | 2021 | 108 | 0.050 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2000 | 3 | 0.050 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2000 | 8 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2013 | 420 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 1 | 2005 | 311 | 0.050 |
Why?
|
| Water | 1 | 2022 | 277 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2005 | 592 | 0.050 |
Why?
|
| Urination | 1 | 2000 | 37 | 0.050 |
Why?
|
| Biomimetics | 1 | 2020 | 29 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 318 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 118 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 1156 | 0.050 |
Why?
|
| Intuition | 1 | 2020 | 8 | 0.050 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 111 | 0.050 |
Why?
|
| Cattle | 1 | 2020 | 376 | 0.040 |
Why?
|
| Acute Disease | 1 | 2001 | 826 | 0.040 |
Why?
|
| Aged | 5 | 2005 | 18415 | 0.040 |
Why?
|
| Illinois | 1 | 2021 | 462 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 285 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2020 | 143 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 130 | 0.040 |
Why?
|
| Allografts | 1 | 2020 | 172 | 0.040 |
Why?
|
| DNA | 1 | 2005 | 1294 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 2019 | 25 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 408 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2019 | 17 | 0.040 |
Why?
|
| Adipocytes | 1 | 2020 | 155 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 197 | 0.040 |
Why?
|
| Marfan Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 130 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2020 | 227 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2018 | 59 | 0.040 |
Why?
|
| Radiography | 2 | 2012 | 813 | 0.040 |
Why?
|
| Albumins | 1 | 2019 | 133 | 0.040 |
Why?
|
| North America | 1 | 2018 | 180 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 364 | 0.040 |
Why?
|
| Drainage | 1 | 2019 | 157 | 0.040 |
Why?
|
| Heart Rate | 1 | 2000 | 492 | 0.040 |
Why?
|
| Propensity Score | 1 | 2018 | 136 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 536 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 1078 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 307 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2018 | 175 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 109 | 0.040 |
Why?
|
| Foramen Ovale, Patent | 1 | 2017 | 18 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 187 | 0.040 |
Why?
|
| Actinin | 1 | 2016 | 19 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 309 | 0.040 |
Why?
|
| Rewarming | 1 | 2016 | 5 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1924 | 0.040 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 5 | 0.040 |
Why?
|
| Sternotomy | 1 | 2016 | 20 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2018 | 349 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 360 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2018 | 290 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2705 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 159 | 0.030 |
Why?
|
| Prognosis | 1 | 2003 | 3679 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 702 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 262 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2014 | 24 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2014 | 36 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2014 | 45 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 91 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 90 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2015 | 158 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1186 | 0.030 |
Why?
|
| Aspirin | 1 | 2015 | 156 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 134 | 0.030 |
Why?
|
| External Fixators | 1 | 2013 | 19 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2014 | 78 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2021 | 1565 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 154 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 407 | 0.030 |
Why?
|
| Osteonecrosis | 1 | 2012 | 21 | 0.030 |
Why?
|
| Ribs | 1 | 2012 | 45 | 0.030 |
Why?
|
| Elastin | 1 | 2011 | 7 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2011 | 28 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1219 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 1 | 2011 | 27 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2767 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 2011 | 113 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 195 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2011 | 80 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 47 | 0.020 |
Why?
|
| Cyanosis | 1 | 2009 | 9 | 0.020 |
Why?
|
| Heart Murmurs | 1 | 2009 | 6 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2009 | 58 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 272 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 363 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2008 | 116 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 430 | 0.020 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2005 | 12 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2005 | 62 | 0.020 |
Why?
|
| Epistaxis | 1 | 2005 | 19 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 238 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 469 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2005 | 221 | 0.010 |
Why?
|
| Rheumatic Heart Disease | 1 | 2003 | 29 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 2003 | 37 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1749 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2002 | 43 | 0.010 |
Why?
|